Supporting the goals and ideals of a Juan Pablo Duarte Day.
- Last Action
- 1/22/2019
Actions
- 2019-01-25Referred to the Subcommittee on Health.
- 2019-01-03Referred to the House Committee on Energy and Commerce.
- 2019-01-03Introduced in House
- 2019-01-03Introduced in House
CRS Summary
As of 2019-01-03 (00)
Patients First Act of 2019
This bill requires the National Institutes of Health (NIH) to support stem cell research. Specifically, the NIH must conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions. However, such techniques must not involve (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this bill.
The NIH must also report on peer-reviewed stem cell research proposals that were not funded.
Cosponsors (14)
- CHRISTOPHER SMITH (R-NJ)
- Rick Allen (R-GA)
- Alexander Mooney (R-WV)
- Doug Lamborn (R-CO)
- Earl Carter (R-GA)
- Trent Kelly (R-MS)
- Gus Bilirakis (R-FL)
- Bill Flores (R-TX)
- Jim Jordan (R-OH)
- Roger Marshall (R-KS)
- Glenn Grothman (R-WI)
- Mike Johnson (R-LA)
- Mark Green (R-TN)
- Warren Davidson (R-OH)
Subjects
- Administrative law and regulatory procedures
- Cell biology and embryology
- Department of Health and Human Services
- Government studies and investigations
- Medical ethics
- Medical research
- Research administration and funding
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.